| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.766 | 17.217 | 16.142 | 20.505 | 60.119 | 61.787 | 15.433 |
| Total Income - EUR | - | - | - | 4.766 | 17.217 | 16.142 | 20.505 | 60.370 | 61.787 | 40.440 |
| Total Expenses - EUR | - | - | - | 4.345 | 5.194 | 11.708 | 18.005 | 12.378 | 20.622 | 23.975 |
| Gross Profit/Loss - EUR | - | - | - | 421 | 12.023 | 4.434 | 2.500 | 47.992 | 41.165 | 16.465 |
| Net Profit/Loss - EUR | - | - | - | 278 | 11.507 | 3.960 | 1.897 | 46.644 | 40.621 | 15.507 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Lucamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 5 | 34.070 | 27.905 | 23.289 | 16.333 | 10.345 | 69.472 |
| Current Assets | - | - | - | 1.864 | 1.840 | 2.669 | 1.882 | 31.092 | 32.813 | 12.752 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 995 | 0 | 29.992 | 19.433 | 13.111 |
| Cash | - | - | - | 1.864 | 1.840 | 1.674 | 1.882 | 1.100 | 13.380 | -359 |
| Shareholders Funds | - | - | - | 321 | 11.557 | 4.009 | 1.946 | 46.692 | 42.437 | 26.022 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.549 | 24.596 | 26.564 | 23.226 | 1.687 | 721 | 56.203 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lucamed S.r.l.